EPIDEMIOLOGY OF IDIOPATHIC CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS - A NATIONWIDE STUDY IN FINLAND

Citation
A. Arola et al., EPIDEMIOLOGY OF IDIOPATHIC CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS - A NATIONWIDE STUDY IN FINLAND, American journal of epidemiology, 146(5), 1997, pp. 385-393
Citations number
47
Categorie Soggetti
Public, Environmental & Occupation Heath
ISSN journal
00029262
Volume
146
Issue
5
Year of publication
1997
Pages
385 - 393
Database
ISI
SICI code
0002-9262(1997)146:5<385:EOICIC>2.0.ZU;2-1
Abstract
Although idiopathic cardiomyopathies are prognostically important and are a common indication for cardiac transplantation in all age groups, the incidence and age distribution of idiopathic cardiomyopathies in a well-defined pediatric population have been poorly characterized. A retrospective study was carried out in Finland in 1980-1991 to obtain information on the epidemiology of childhood cardiomyopathies. The med ical records of all patients aged birth to 20 years with cardiomyopath y from the five university hospitals and 16 central hospitals covering the entire country were reviewed. Moreover, data on causes of death f rom the Finnish National Census Bureau were examined. Of the 808 poten tial cases screened, 118 infants, children, and adolescents, represent ing an average age-specific population of 1.4 million, were definitely identified as having idiopathic cardiomyopathy. The average annual oc currence of new cases was 0.65 per 100,000 population (95% confidence interval (CI) 0.53-0.79). If the 15 cases diagnosed only after death d uring the 12-year study period were included, the occurrence increased to 0.74 per 100,000 population per year. Fifty-six new cases of dilat ed cardiomyopathy and 40 new cases of hypertrophic cardiomyopathy were diagnosed during the study period, giving average annual occurrences of 0.34/100,000/year (95% CI 0.26-0.44) and 0.24/100,000/year (95% CI 0.17-0.33) for new cases of dilated and hypertrophic cardiomyopathies, respectively. At the end of 1991, the prevalence of dilated cardiomyo pathy was 2.6/100,000 (95% CI 1.8-3.6) and that for hypertrophic cardi omyopathy was 2.9/100,000 (95% CI 2.0-4.0). The number of new cases of dilated cardiomyopathy per year increased over the study period, wher eas the annual occurrence of hypertrophic cardiomyopathy remained rela tively constant. Marked variability was seen in occurrence among the d ifferent age groups of children with dilated cardiomyopathy, suggestin g that different pathophysiologic mechanisms, and possibly etiologies, may exist in different age groups.